Zimbabwe has rejected a substantial American healthcare agreement worth $367m (£272m) spanning five years because of Washington's request for confidential information.
The decision became public after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
A government representative later explained that the US was demanding access to genetic material for scientific study and profit but refused to guarantee the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for more dialogue to find a deal suitable to both sides so the country's critical HIV programme can continue.
Broader Background
This development comes after a similar situation in neighbouring Kenya, where a high court halted a related deal with the US after concerns were filed about the security of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance transparency and responsibility.
According to statements, 16 African countries have so far signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported initiatives," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the end products would be available to our citizens should a future disease outbreak emerge."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting systems previously established through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing system created to manage future pandemics.
"This framework is designed to ensure that when a nation provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
These objections regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome further dialogue with our American counterparts on how future co-operation could be arranged in a manner that honours the sovereignty and interests of both nations."
Medical Community Response
Medical experts stated it acknowledged the official position, but recommended that talks must proceed given that much of the nation's HIV programmes relied on international support.
"In cases where technical issues arise, such as those relating to information security or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," the group commented.
The halted deal highlights the continuing challenges between receiving crucial international aid and safeguarding a country's data in an ever more data-driven world.